Alembic Pharmaceuticals Limited has informed the Exchange regarding Change in Auditors of the company.
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts more than Nifty Microcap 250 and 2.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
At the 15th Annual General Meeting held on 5th August 2025, shareholders of Alembic Pharmaceuticals approved the appointment of M/s. KKC & Associates LLP (formerly Khimji Kunverji & Co. LLP) as the new Statutory Auditors for a period of 5 years, i.e., from 5th August 2025 until the AGM for FY 2029-30. They replace the retiring auditors, M/s. K.C. Mehta & Co. LLP, upon completion of their term. The company also appointed M/s. Samdani Shah & Kabra, a peer-reviewed firm of Practising Company Secretaries, as the Secretarial Auditor for a 5-year term covering FY 2025-26 to FY 2029-30. KKC & Associates LLP, established in 1936, is a peer-reviewed firm with over 200 members experienced in auditing large manufacturing, banking, and NBFC companies.
This is a routine, end-of-term rotation of auditors and not a mid-term resignation or governance concern, so it is unlikely to have any material impact on the stock. Shareholders should note the continuity of professional oversight with a well-established audit firm.